Yahoo Web Search

Search results

  1. 4 days ago · Earnings for CRISPR Therapeutics are expected to grow in the coming year, from ($5.51) to ($4.44) per share. CRISPR Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 5th, 2024 based off prior year's report dates.

    • Institutional Ownership

      Of the 324 institutional investors that purchased CRISPR...

    • Options Chain

      View the latest CRSP options chain and put and call options...

    • Halo

      Earnings for Halozyme Therapeutics are expected to grow by...

    • Imvt

      Earnings for Immunovant are expected to decrease in the...

    • Dnli

      Earnings for Denali Therapeutics are expected to decrease in...

  2. Earnings Date May 8, 2024; Forward Dividend & Yield--Ex-Dividend Date--1y Target Est 84.29

  3. A high-level overview of CRISPR Therapeutics AG (CRSP) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  4. 1 day ago · Look out for CRSP's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$1.37 per share, reflecting a year-over-year...

  5. Feb 14, 2024 · CRISPR Therapeutics (CRSP) is expected to report fourth-quarter and full-year 2023 results on Feb 15, 2024. The company will provide updates on the sales numbers of its gene therapy Casgevy, which was approved for sickle cell disease and beta thalassemia in the US and Europe, and its CAR-T candidates CTX112 and CTX131.

  6. Get the latest Crispr Therapeutics AG (CRSP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  7. People also ask

  8. Feb 21, 2023 · ZUG, Switzerland and BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today reported financial results for the fourth quarter and full year ended December 31, 2022.

  1. People also search for